Literature DB >> 17400931

Implantation site-dependent dysfunction of transplanted pancreatic islets.

Joey Lau1, Göran Mattsson, Carina Carlsson, Daniel Nyqvist, Martin Köhler, Per-Olof Berggren, Leif Jansson, Per-Ola Carlsson.   

Abstract

OBJECTIVE: Clinical islet transplantations are performed through infusion of islets via the portal vein into the liver. This study aimed at characterizing the influence of the implantation microenvironment on islet graft metabolism and function. RESEARCH DESIGN AND METHODS: Islets were transplanted into their normal environment, i.e., the pancreas, or intraportally into the liver of mice. One month posttransplantation, the transplanted islets were retrieved and investigated for changes in function and gene expression.
RESULTS: Insulin content, glucose-stimulated insulin release, (pro)insulin biosynthesis, and glucose oxidation rate were markedly decreased in islets retrieved from the liver, both when compared with islets transplanted into the pancreas and endogenous islets. Islets transplanted into the pancreas showed normal insulin content, (pro)insulin biosynthesis, and glucose oxidation rate but increased basal insulin secretion and impaired glucose stimulation index. Gene expression data for retrieved islets showed downregulation of pancreatic and duodenal homeobox gene-1, GLUT-2, glucokinase, mitochondrial glycerol-phosphate dehydrogenase, and pyruvate carboxylase, preferentially in intraportally transplanted islets.
CONCLUSIONS: Islets transplanted into their normal microenvironment, i.e., the pancreas, display gene expression changes when compared with endogenous islets but only moderate changes in metabolic functions. In contrast, site-specific properties of the liver markedly impaired the metabolic functions of intraportally transplanted islets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400931     DOI: 10.2337/db06-1258

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

Review 1.  Islet transplantation: alternative sites.

Authors:  Amer Rajab
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 2.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

Review 3.  Bioengineered sites for islet cell transplantation.

Authors:  Sophie Vériter; Pierre Gianello; Denis Dufrane
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 4.  Alternative transplantation sites for pancreatic islet grafts.

Authors:  Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

Review 5.  Concise review: pancreas regeneration: recent advances and perspectives.

Authors:  Philippe A Lysy; Gordon C Weir; Susan Bonner-Weir
Journal:  Stem Cells Transl Med       Date:  2012-01-26       Impact factor: 6.940

Review 6.  Islet transplantation a decade later and strategies for filling a half-full glass.

Authors:  R Paul Robertson
Journal:  Diabetes       Date:  2010-06       Impact factor: 9.461

7.  Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.

Authors:  Chunyan Zhang; Miao Wang; Jeremy J Racine; Hongjun Liu; Chia-Lei Lin; Indu Nair; Joyce Lau; Yu-An Cao; Ivan Todorov; Mark Atkinson; Defu Zeng
Journal:  Diabetes       Date:  2010-06-08       Impact factor: 9.461

8.  Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes.

Authors:  Vijay Yechoor; Victoria Liu; Christie Espiritu; Antoni Paul; Kazuhiro Oka; Hideto Kojima; Lawrence Chan
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

9.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

10.  Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation.

Authors:  Jing Su; Bi-Huang Hu; William L Lowe; Dixon B Kaufman; Phillip B Messersmith
Journal:  Biomaterials       Date:  2009-09-25       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.